• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名携带新型PRKAR1A突变的患者出现的卡尼综合征的不寻常表现。

Unusual presentations of Carney Complex in patient with a novel PRKAR1A mutation.

作者信息

Akin Safak, Noyan Senem, Dagdelen Selcuk, Pasaoglu Ilhan, Kaynaroglu Volkan, Askun Melike Mut, Bilen Cenk Yucel, Kiratli Hayyam, Baydar Dilek Ertoy, Onder Sevgen, Sokmensuer Cenk, Aytemir Kudret, Erkin Gul, Kiratli Pinar Ozgen, Alikasifoglu Mehmet, Erbas Tomris

机构信息

Hacettepe University, Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, Turkey.

Damagen, Ankara, Turkey.

出版信息

Neuro Endocrinol Lett. 2017 Aug;38(4):248-254.

PMID:28871709
Abstract

Carney Complex (CNC) is a multiple neoplasia syndrome characterized by skin tumors and pigmented lesions, myxomas, and various endocrine tumors. The aim of this case report was to describe a case of CNC with a novel PRKAR1A mutation. A man aged 46 years with a medical history of surgery for cardiac myxomas at the age of 39 was admitted to our hospital because of four newly-developed heart masses. The histologic examination confirmed cardiac myxomas. He had many presentations of CNC such as growth hormone (GH) and prolactin (PRL)-secreting mixed pituitary adenoma, benign thyroid nodule, large-cell calcifying Sertoli cell tumor (LCCST), and superficial angiomyxoma. A bilateral adrenalectomy was performed because the laboratory findings suggested primary pigmented nodular adrenocortical disease (PPNAD). The pathologic examination revealed a focal unilateral PPNAD, unilateral nonpigmented adrenocortical nodule, and bilateral adrenal medullary hyperplasia. Two years after the second cardiac operation, an interatrial septum-derived tumor was detected. An atrial myxoma was confirmed with histologic studies. Based on these findings, the patient was confirmed to have CNC. A novel insertion mutation in the type 1A regulatory subunit of the cAMP-dependent protein kinase A gene (PRKAR1A) in exon 2 was detected in our patient through genetic analysis. The presence of multiple myxomas and endocrine abnormalities should be an indication to physicians to further investigate for CNC. Herein, we described a case of CNC with a novel mutation in exon 2 of the PRKAR1A gene with typical and atypical clinical features.

摘要

卡尼综合征(CNC)是一种多发性肿瘤综合征,其特征为皮肤肿瘤和色素沉着病变、黏液瘤以及各种内分泌肿瘤。本病例报告的目的是描述一例具有新型PRKAR1A突变的CNC病例。一名46岁男性,有39岁时因心脏黏液瘤接受手术的病史,因新出现的4个心脏肿物入住我院。组织学检查证实为心脏黏液瘤。他有许多CNC的表现,如生长激素(GH)和催乳素(PRL)分泌性混合垂体腺瘤、良性甲状腺结节、大细胞钙化性支持细胞瘤(LCCST)和浅表血管黏液瘤。由于实验室检查结果提示原发性色素沉着性结节性肾上腺皮质疾病(PPNAD),故行双侧肾上腺切除术。病理检查显示局灶性单侧PPNAD、单侧无色素肾上腺皮质结节和双侧肾上腺髓质增生。第二次心脏手术后两年,检测到一个房间隔来源的肿瘤。组织学研究证实为心房黏液瘤。基于这些发现,该患者被确诊为CNC。通过基因分析在我们的患者中检测到环磷酸腺苷依赖性蛋白激酶A基因(PRKAR1A)1A型调节亚基外显子2中的一种新型插入突变。多个黏液瘤和内分泌异常的存在应提示医生进一步调查是否为CNC。在此,我们描述了一例PRKAR1A基因外显子2具有新型突变且具有典型和非典型临床特征的CNC病例。

相似文献

1
Unusual presentations of Carney Complex in patient with a novel PRKAR1A mutation.一名携带新型PRKAR1A突变的患者出现的卡尼综合征的不寻常表现。
Neuro Endocrinol Lett. 2017 Aug;38(4):248-254.
2
[Carney complex].[卡尼综合征]
Endocrinol Nutr. 2011 Jun-Jul;58(6):308-14. doi: 10.1016/j.endonu.2011.03.001. Epub 2011 May 4.
3
Frequent protein kinase A regulatory subunit A1 mutations but no GNAS mutations as potential driver in sporadic cardiac myxomas.散发性心脏黏液瘤中常见蛋白激酶A调节亚基A1突变,但无GNAS突变作为潜在驱动因素。
Cardiovasc Pathol. 2024 Jul-Aug;71:107632. doi: 10.1016/j.carpath.2024.107632. Epub 2024 Mar 15.
4
PRKAR1A in the development of cardiac myxoma: a study of 110 cases including isolated and syndromic tumors.PRKAR1A 在心脏黏液瘤发病机制中的作用:110 例孤立性和综合征性肿瘤的研究。
Am J Surg Pathol. 2014 Aug;38(8):1079-87. doi: 10.1097/PAS.0000000000000202.
5
Case Report: An Atypical Case of Carney Complex.病例报告:卡尼综合征的一个非典型病例。
Am J Case Rep. 2021 Oct 24;22:e933744. doi: 10.12659/AJCR.933744.
6
mutation causing pituitary-dependent Cushing disease in a patient with Carney complex.导致患有卡尼综合征的患者垂体依赖性库欣病的突变。
Eur J Endocrinol. 2017 Aug;177(2):K7-K12. doi: 10.1530/EJE-17-0227. Epub 2017 May 18.
7
Carney complex: a clinicopathologic and molecular biological study of a sporadic case, including extracutaneous and cutaneous lesions and a novel mutation of the PRKAR1A gene.卡尼综合征:1例散发病例的临床病理及分子生物学研究,包括皮肤外和皮肤病变以及PRKAR1A基因的新突变
J Am Acad Dermatol. 2009 Jul;61(1):80-7. doi: 10.1016/j.jaad.2008.11.015.
8
Carney complex (CNC).卡尼综合征(CNC)。
Orphanet J Rare Dis. 2006 Jun 6;1:21. doi: 10.1186/1750-1172-1-21.
9
A Novel Inherited Mutation in PRKAR1A Abrogates PreRNA Splicing in a Carney Complex Family.PRKAR1A基因中的一种新型遗传性突变导致卡尼综合征家族中的前体RNA剪接异常。
Can J Cardiol. 2015 Nov;31(11):1393-401. doi: 10.1016/j.cjca.2015.05.018. Epub 2015 May 30.
10
A large family with Carney complex caused by the S147G PRKAR1A mutation shows a unique spectrum of disease including adrenocortical cancer.一个由 S147G PRKAR1A 突变引起的 Carney 复合征的大家族表现出独特的疾病谱,包括肾上腺皮质癌。
J Clin Endocrinol Metab. 2012 Feb;97(2):351-9. doi: 10.1210/jc.2011-2244. Epub 2011 Nov 23.

引用本文的文献

1
The clinical characteristics and pathogenic variants of primary pigmented nodular adrenocortical disease in 210 patients: a systematic review.210 例原发性色素性结节性肾上腺皮质病的临床特征和致病变异体:系统评价。
Front Endocrinol (Lausanne). 2024 Jun 26;15:1356870. doi: 10.3389/fendo.2024.1356870. eCollection 2024.
2
Carney complex- why thorough medical history taking is so important - report of three cases and review of the literature.卡尼复合体——为何详尽的病史采集至关重要——三例报告并文献复习。
Endocrine. 2023 Apr;80(1):20-28. doi: 10.1007/s12020-022-03209-2. Epub 2022 Oct 18.
3
Acromegaly in Carney complex.
卡尼综合征相关的肢端肥大症。
Pituitary. 2019 Oct;22(5):456-466. doi: 10.1007/s11102-019-00974-8.
4
Convergent Identification and Interrogation of Tumor-Intrinsic Factors that Modulate Cancer Immunity In Vivo.体内肿瘤内在因素的会聚鉴定和干扰对癌症免疫的影响。
Cell Syst. 2019 Feb 27;8(2):136-151.e7. doi: 10.1016/j.cels.2019.01.004. Epub 2019 Feb 20.